Skip to main content
. 2023 Jul 21;15(7):2000. doi: 10.3390/pharmaceutics15072000

Figure 6.

Figure 6

The interaction analysis of the active NTSR1 + SR48692 system (active state) (A), the active NTSR1 + SR48692 system (intermediate state) (B), the active NTSR1 + SR48692 system (inactive state) (C), and the active NTSR1 + ML301 system (D). Y3196.51-F3537.42-R1483.32 interactions are enlarged for clarity.